InvestoGain Australia ASA Conference 2016 WEB

SEARCH BY NAME

BROWSE

Browse Australian listed companies0-9A BC DE FGH IJ KL MN OP QR ST UV WX YZ
Browse current Australian managed funds0-9A BCDE FGH IJKL MNOP QRST UVWX YZ

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

REVA MEDICAL, INC (RVA)

Listed on ASX ( $1.085    -0.005    -0.459%)

Former (or subsequent) names

 

Shareholder links

Our website ranking of RVA: rating 4
(4 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Computershare, Level 3, 60 Carrington Street, Sydney NSW 2000

Tel : +61 2 8234 5000
Fax : +61 2 8235 8150
RegistryWebsite RegistryEmail

Company details

Address: c/o Buchan Pty. Ltd. (“Buchan”) Suite 4, Level 14 6 O’Connell Street Sydney, NSW 2000
Tel:  (858) 966-3000 Fax: (858) 966-3099

Date first listed: 23/12/2010
Company Secretary: Katrina Thompson
Sector:  INC" Industry Group: Health Care Equipment & Services
Activities: Development of medical devices, specifically bioresorbable stent products
listed entity carried for record purposes only23/12/2010

ASX Announcements (courtesy of ASX)

Date Price
sens.
Headline Pages PDF
Date Price
sens.
Headline Pages PDF Edited
text*
02/05/2016   Proxy Statement for 2016 AGM 52 PDF -
29/04/2016   Appendix 3B 6 PDF -
29/04/2016 asterix Appendix 4C - quarterly 7 PDF -
06/04/2016   Change of Director's Interest Notice 2 PDF -
31/03/2016   Change of Director's Interest Notice 4 PDF -
30/03/2016   Brian Dovey Elected Chairman 2 PDF -
23/03/2016   Results of Special Meeting 2 PDF -
16/03/2016   Details for Special Meeting of Stockholders 1 PDF -
11/03/2016   Annual Report on Form 10-K 100 PDF -
11/03/2016   Form S-8 Filed with SEC 9 PDF -
11/03/2016 asterix S&P DJ Indices Announces March Quarterly Review 9 PDF -
09/03/2016   Proxy Statement for Special Meeting of Stockholders 28 PDF -
08/03/2016   Notice of Briefing Call 1 PDF -
26/02/2016 asterix Preliminary Final Report 29 PDF -
24/02/2016 asterix FANTOM II Target Patient Enrollment Achieved 2 PDF -
22/02/2016   Appendix 3B 7 PDF -
16/02/2016   Notice of Change of Substantial Holders 2 PDF -
16/02/2016   Becoming a substantial holder 2 PDF -
16/02/2016   Appendix 3B 8 PDF -
11/02/2016 asterix Clinical Progress & Anticipated $11.4 Million Cash Receipt 2 PDF -

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    Posting your comments. Please wait...


    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNATURENUMBERPRICEAMOUNT
    31/03/2016Robert ThomasOn market CDIs25,000 $1.100$27,500
    29/03/2016Robert StockmanOn market CDIs65,000 $1.116$72,566
    04/06/2015Ross BreckenridgeOn market CDIs10,000 $0.530$5,300
    03/06/2015Robert StockmanOn market CDIs62,500 $0.513$32,069
    29/05/2015Robert ThomasOn market CDIs100,000 $0.502$50,190

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Brian DoveyChairman12/06/2001
    Regina GrovesCEO21/09/2015
    Katrina ThompsonCFO
    Robert StockmanNon Exec Director01/12/1999
    Ross BreckenridgeNon Exec Director29/01/2015
    Scott HuennekensNon Exec Director26/03/2015
    Gordon NyeDirector16/05/2001
    Robert ThomasDirector28/07/2010
    Anne KeatingDirector01/10/2010

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    James SchiroDirector09/11/201025/07/2014

    Date of first appointment, title may have changed.